| Particulars |
| Company Name |
Aurobindo Pharma Ltd |
| Face Value |
1 |
| BSE Code |
524804 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
58.08 |
| B.V. Rs |
391.10 |
| Sales Rs in Cr. |
11,055.39 |
| NP Rs in Cr. |
2,428.07 |
| NP Var% |
39.00 |
| Div% |
400.00 |
| CPS Rs |
46.70 |
| EPS Rs |
41.80 |
| Traded Value(Rs in Lakhs) |
1,070.27 |
| 52 Week High |
1,586.00 |
| 52 Week Low |
1,017.00 |
| Price BSE |
1,549.00 |
| Price NSE |
1,548.00 |
| Market Capital(Rs in Cr.) |
89,957.46 |
| P/C Ratio |
33.20 |
| P/E Ratio |
37.10 |
| Price Vs.BV |
3.96 |
| Latest Quarter |
| Year End |
202603 |
| Sales Rs in Cr. |
2,746.98 |
| NP Rs in Cr. |
692.23 |
| NP Var % |
70.00 |
| Trailing Twelve Months |
| Year End |
202603 |
| Sales |
10,713.37 |
| OPM |
23.28 |
| NP |
2,069.02 |
| NP Var% |
39.44 |
| EPS |
41.81 |
| PE |
37.04 |
|